This workshop is aimed at doctors, stroke neurologists, and investogators keen to run the CASPER study at their site.
Session hosts, Adrian and Karly, set the scene and speak from experience about their motivations and journey into research, give context to different engagement levels, and approaches to advocate for self and others to create effective, successful participation.
This is a closed session for lived-experience delegates with opportunities to ask questions and learn from others participating.
Speakers/Facilitators:
Adrian O’Malley, Lived-experience contributor
Karly Zacharia, University of Newcastle researcher
In the first hour, three different pairs of researcher/lived-experience contributors will share some real-life examples of how to undertake ‘co-design’ (and some pitfalls to avoid). Tips and tricks and practical resources will be shared.
In the last half hour, the speakers will join in a panel conversation.
This is an interactive session for all conference attendees with opportunities to ask questions and learn from others participating. For lived-experience delegates it will build on Workshop 1. This session will also appeal to researchers wanting to learn more about co-design principles and get practical tips to improve how to involve those with lived experience in their research.
Speakers/Facilitators:
Chris Lassig, Stroke Foundation
Saran ChamberlainLived-experience contributor
Elizabeth Lynch, Flinders University researcher
Brooke Parsons,Lived-experience contributor
Julie Bernhardt, Florey Institute researcher
Vikki Cail, Lived-experience contributor
John Pierce, La Trobe University researcher
Session Objective:
To provide an overview of the current usage of FXa-Inhibitors in Australia and the impact that they have in ICH and its management and to review the current reversal strategies for FXa-Inhibitors in ICH and their place in the current treatment paradigm.
Participants
Chair – Andrew Wong
Presenters – Huyen Tran and Geoff Cloud
Schedule
Time |
Topics |
Presenter |
12:30 – 12:35 PM |
Welcome and Introductions |
Associate Professor. Andrew Wong |
12:35 PM – 12:50 PM |
FXa inhibitors – mechanism of action and reversal strategies |
Professor. Huyen Tran |
12:50 PM – 1:05 PM |
How to best manage FXa inhibitors associated ICH in 2023 |
Professor. Geoff Cloud |
1:05 PM – 1:20 PM |
Panel Discussion |
All attendees |
1:20 PM – 1:25 PM |
Summary and Closing Remarks |
Associate Professor. Andrew Wong |
The conference scientific committee has selected the best co-design abstracts to be presented.
At the end of the session, the co-design research abstract speakers join a panel with session facilitators for discussion and interactive Q&A for all conference attendees.
Facilitated by:
Brenda Booth, Lived-experience contributor
Felicity Bright, Auckland University of Technology researcher
The conference scientific committee has selected the best co-design abstracts to be presented.
At the end of the session, the co-design research abstract speakers join a panel with session facilitators for discussion and interactive Q&A for all conference attendees.
Facilitated by:
Elisha Deegan, Lived-experience contributor
Adrian O’Malley, Lived-experience contributor
Sarah Wallace, University of Queensland researcher
Participants: Bruce Campbell and Teddy Wu